MENU
AGYTF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Allergy Therapeutics (AGYTF) Ownership - Who owns Allergy Therapeutics?
Profile
Industry
N/A
Address
Dominion Way
Phone
+44 1903844700
Employees
622
Web
https://www.allergytherapeutics.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
25.84M
P/E Ratio
49.26
Total Cash
41.39M
Projected Growth
N/A
Total Debt
9.93M
Revenue
79M
Risk (Beta)
902.37
Dividend Yield
N/A
Total Cash/Share
0.06
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price
Fundamentals
AGYTF
Capitalization
25.8M
P/E Ratio
49.26
Risk (Beta)
902.37
Dividend Yield
N/A
Total Cash
41.4M
Total Cash/Share
0.06
Total Debt
9.93M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
79M
ROE
N/A
Book Value
55M
P/B Ratio
2.48
Cash Flow
N/A
Earnings
-0.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
652K
Current Ratio
3.80
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
302K
Float
N/A
Float - Current
N/A
Gross Income Margin
70.75
Revenue To Assets
-5.64
Shares Held By Institutions
76.2K
Shares Outstanding - Current
679M
Total Liabilities
37M
Total Volume MTD
N/A
Value
-1
Gain YTD
420.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
N/A
Address
Dominion Way
Phone
+44 1903844700
Employees
622
Web
https://www.allergytherapeutics.com